Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373814 | Bioorganic & Medicinal Chemistry Letters | 2010 | 7 Pages |
Abstract
We report the identification of a novel NR2B-selective NMDAR antagonist with an original scaffold, LSP10-0500. This compound was identified by a virtual high-throughput screening approach on the basis of a quantitative pharmacophore model of NR2B-specific NMDAR antagonists. A SAR study around LSP10-0500 is also described.
Graphical abstractA novel NR2B-selective NMDAR antagonist, LSP10-0500, was identified using a ligand-based virtual screening approach.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Laetitia Mony, Nicolas Triballeau, Pierre Paoletti, Francine C. Acher, Hugues-Olivier Bertrand,